Pfizer to sell its patented drugs at nonprofit price to low-income nations

Pfizer announced on Wednesday that it will now sell all of its patented medicines at a not-for-profit price to 45 of the world’s poorest countries. The drug company has been accused of “pandemic profiteering” over the billions of dollars it’s made over the past few years. Host Marco Werman speaks with Jamie Love of Knowledge Ecology International, an NGO that focuses on the effects of intellectual property on public health, about the significance of this gesture.

Sign up for our daily newsletter

Sign up for The Top of the World, delivered to your inbox every weekday morning.